These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3313907

  • 21. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody.
    Mizutani K, Terasaki PI, Shih RN, Pei R, Ozawa M, Lee J.
    Hum Immunol; 2006 Mar; 67(3):223-9. PubMed ID: 16698446
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A, Siddiqui JA, Rai A, Margoob A, Khaira A, Bhowmik D, Tiwari SC, Guleria S, Mehra NK.
    Clin Transpl; 2007 Mar; ():211-7. PubMed ID: 18637472
    [Abstract] [Full Text] [Related]

  • 24. Antibody-mediated rejection.
    Akalin E, Watschinger B.
    Semin Nephrol; 2007 Jul; 27(4):393-407. PubMed ID: 17616272
    [Abstract] [Full Text] [Related]

  • 25. Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival.
    Lee PC, Ozawa M, Hung CJ, Lin YJ, Chang SS, Chou TC.
    Transplant Proc; 2009 Jul; 41(1):121-3. PubMed ID: 19249493
    [Abstract] [Full Text] [Related]

  • 26. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N, Terasaki PI, Schönemann C.
    Clin Transpl; 2006 Jul; ():171-99. PubMed ID: 18365377
    [Abstract] [Full Text] [Related]

  • 27. Specificity of antibody developed in recipients who reject their HLA identical living related grafts.
    Cerilli J, Brasile L, Clarke J.
    Prog Clin Biol Res; 1983 Jul; 133():251-6. PubMed ID: 6353419
    [No Abstract] [Full Text] [Related]

  • 28. Impact of diabetes mellitus on transplantation.
    Waki K.
    Clin Transpl; 2004 Jul; ():357-77. PubMed ID: 16704163
    [Abstract] [Full Text] [Related]

  • 29. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L, Conca R, Magistroni P, Leonardi G, Oda A, Rosati F, Leone E, Tacconella M, Roggero S, Segoloni GP, Amoroso A.
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [Abstract] [Full Text] [Related]

  • 30. Blood transfusions and their influence on renal allograft survival.
    Rodey GE.
    Prog Hematol; 1986 Jul; 14():99-122. PubMed ID: 3511519
    [No Abstract] [Full Text] [Related]

  • 31. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades.
    Opelz G, Döhler B.
    Transplantation; 2007 Jul 27; 84(2):137-43. PubMed ID: 17667803
    [Abstract] [Full Text] [Related]

  • 32. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2009 Aug 27; 70(8):589-94. PubMed ID: 19375470
    [Abstract] [Full Text] [Related]

  • 33. HLA-A, B matching of pretransplant blood transfusion is associated with poor graft survival.
    Albert ED, Scholz S, Meixner U, Land W.
    Transplant Proc; 1981 Mar 27; 13(1 Pt 1):175-7. PubMed ID: 7022817
    [No Abstract] [Full Text] [Related]

  • 34. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
    Worthington JE, Martin S, Barker AJ, McWilliam LJ, Dyer PA.
    Clin Transpl; 2006 Mar 27; ():349-61. PubMed ID: 18365389
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J.
    J Am Soc Nephrol; 2004 Dec 27; 15(12):3256-62. PubMed ID: 15579530
    [Abstract] [Full Text] [Related]

  • 36. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD.
    J Am Soc Nephrol; 2005 Sep 27; 16(9):2804-12. PubMed ID: 16014742
    [Abstract] [Full Text] [Related]

  • 37. Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience.
    van den Berg-Loonen EM, Terasaki P, Kohanof S, Christiaans MH.
    Clin Transpl; 2006 Sep 27; ():305-22. PubMed ID: 18365386
    [Abstract] [Full Text] [Related]

  • 38. The effect of 3-4 HLA-A and -B antigen mis-matched cadaveric kidney transplants on graft and patient survival.
    Solheim BG, Flatmark A, Halvorsen S, Jervell J, Thorsby E.
    Scand J Urol Nephrol Suppl; 1980 Sep 27; 54():37-40. PubMed ID: 7013040
    [Abstract] [Full Text] [Related]

  • 39. Extracorporeal immunoadsorption of anti-HLA antibodies: preliminary clinical experience.
    Palmer A, Taube D, Welsh K, Brynger H, Delin K, Gjörstrup P, Konar J, Söderström T.
    Transplant Proc; 1987 Oct 27; 19(5):3750-1. PubMed ID: 3313909
    [No Abstract] [Full Text] [Related]

  • 40. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
    Sumitran-Holgersson S.
    Curr Opin Immunol; 2008 Oct 27; 20(5):607-13. PubMed ID: 18675346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.